While the extracellular accumulation of amyloid plaques and intra-neuronal presence of tau-containing neurofibrillary tangles may lead to neuron and synapse loss in AD, there is evidence that myelin damage in preclinical AD independently contributes to disease progression [29, 30]. Here, MAPT is linked to Alzheimer disease.